ScholarIQanswers from OpenAlex

Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer

PaperCitations, authors & open-access status

Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer have?

ScholarIQcitation count

Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer has 131 citations in the OpenAlex counts ScholarIQ stores.

When was Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer published?

ScholarIQyear

Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer has 2007 year in the ScholarIQ index.

What is the open-access status of Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer?

ScholarIQoa status

Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer has closed oa status in the ScholarIQ index.

What is the DOI of Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer?

ScholarIQdoi

The DOI for Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer is on the source record.

What is the PMID of Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer?

ScholarIQpmid

The PMID for Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer is on the source record.

What is the OpenAlex record for Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer?

ScholarIQopenalex

The OpenAlex for Intraperitoneal chemotherapy in the first‐line treatment of women with stage III epithelial ovarian cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial